Equity

IDEAYA Biosciences, Inc. (IDYA) Stock — Today's Move

▼ -5.27%

$32.88

$-1.83 today

IDYA is down 5.27% today. Volume is 1.19M vs a 30-day average of 881.9K (1.35x).

Day High

$35.00

Day Low

$32.52

Open

$35.31

Prev Close

$34.71

Volume

1.19M

Avg Vol (30d)

881.9K

52-Wk High

$42.68

52-Wk Low

$26.81

Sector

—

Today's Move

-5.27%

Next Earnings

Mon, Nov 2

IDEAYA Biosciences, Inc. is scheduled to report earnings Mon, Nov 2, 2026. Analysts expect EPS of $-1.21 on revenue of about $6.99M. Stocks often move sharply on earnings day.

52-wk low $26.8152-wk high $42.68

IDYA is 38% of the way from its 52-week low to its high.

Indicators:

Close price · volume bars (dashed line = average volume) · news that day (2M–1Y) — hover or tap the chart. Indicators are for education, not trading advice.

Why is IDYA moving today?

Yahoo· Oct 23, 10:00am

IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates Promising Anti-Tumor Activity and Preliminary Overall Survival Results in Relapsed Small Cell Lung Cancer and Neuroendocrine Carcinomas

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced updated clinical results that show promising anti-tumor activity and preliminary overall survival results for IDE849 (SHR-4…

Yahoo· Oct 19, 10:00am

IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced updated clinical data from three ongoing studies evaluating darovasertib in…

Benzinga· Oct 19, 6:07am

IDEAYA to Present Updated Melanoma Drug Data at Upcoming ESMO Congress

IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a leading precision medicine oncology company, today announced updated clinical data from three ongoing studies evaluating darovasertib in …

Benzinga· Oct 16, 10:42am

William Blair Initiates Coverage On IDEAYA Biosciences with Outperform Rating

William Blair analyst Alethia Young initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform rating.

Related Movers

▼ -48.36%

XP Inc.

Gap Stock Movers: SGRY Leads Gap-Ups and XP Leads Gap-Downs in Today's Session

$15.71 -$14.71

Vol: 132.61M (13.2x avg) Financial Services

INTR

▼ -34.91%

Inter & Co. Inc.

S&P Index Addition Could Change The Case For Inter (INTR) Stock

$4.68 -$2.51

Vol: 55.63M (7.3x avg) Banking

BBD

▼ -28.01%

Banco Bradesco Sa

Most Active Stocks on Oct. 26: RCT, NU and BBD Top Volume

$2.93 -$1.14

Vol: 204.08M (5.3x avg) Banking

SBS

▼ -26.09%

Companhia de saneamento Basico

$4.73 -$1.67

Vol: 54.76M (5.2x avg) Utilities

FAQ — IDYA

Why is IDYA moving today?

IDYA is down 5.27% in the current session. Scroll to the news section below to see the most recent headlines and catalysts driving the move.

Is IDEAYA Biosciences, Inc. a good stock to buy today?

WeeklyTrader.io does not provide financial advice. Always verify catalysts, assess risk, and conduct your own research before making any investment decision.

What is IDYA's average volume?

Average volume for IDYA is approximately 881.9K shares per day based on the trailing 30 sessions.

Where can I see more stocks like IDYA?

Visit the sector filter on the gainers and losers pages to see related movers.